Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
97,759.09
(1.26%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Integral Diagnostics Ltd

IDX

ASX

Internal Diagnostics Limited (IDX) is a provider of medical imaging services across Australia and New Zealand. IDX employs leading radiologists and diagnostic imaging specialists in a unique medical leadership model that ensures quality patient care.

Latest Posts

Line Chart with Gradient
Price
$2.900
0 (0%)
At Close 22/11 (AEST)
Related Companies
INTELICARE HOLDINGS LIMITED
$ICR
CAPITOL HEALTH LIMITED
$CAJ
EBOS GROUP LIMITED
$EBO
OSTEOPORE LIMITED
$OSX
DOCTOR CARE ANYWHERE GROUP PLC
$DOC

Leave a Comment on IDX


Comments for IDX

    Latest Posts

    integral-diagnostics-asx-idx-highlights-strong-fy24-performance-and-strategic-growth-idx
    Health Care $IDX
    Integral Diagnostics (ASX: $IDX) highlights strong FY24 performance and strategic growthCEO discusses financial success, patient-centric values, and expansion in diagnostic imaging services
    November 1, 2024
    lumos-diagnostics-asx-ldx-achieves-first-phase-2-milestone-in-hologic-ffn-development-agreement-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) achieves first phase 2 milestone in hologic fFN development agreement

    Successfully completes milestone under phase 2 of development agreement with Hologic, Inc. for new fetal fibronectin (fFN) test

    September 20, 2024
    lumos-diagnostics-asx-ldx-appoints-thermo-fisher-scientific-as-us-distributor-for-febridx-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) appoints thermo fisher scientific as us distributor for febridx®

    Agreement with Fisher Healthcare to distribute rapid POC respiratory test in the US

    September 16, 2024
    lumos-diagnostics-asx-ldx-conducts-entitlement-offer-to-raise-a10-0-million-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) conducts entitlement offer to raise A$10.0 million

    Entitlement offer aims to fund completion of FebriDx CLIA waiver trial and expand market opportunities

    September 11, 2024
    lumos-diagnostics-asx-ldx-completes-institutional-component-of-entitlement-offer-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) completes institutional component of entitlement offer

    Raises approximately A$3.1 million from institutional and sophisticated investors

    September 6, 2024
    lumos-diagnostics-asx-ldx-requests-trading-halt-for-capital-raising-announcement-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) requests trading halt for capital raising announcement

    Company requests halt for announcement on pro-rata accelerated non-renounceable entitlement offer

    September 4, 2024
    integral-diagnostics-asx-idx-enters-merger-implementation-deed-with-capitol-health-for-proposed-acquisition-idx
    Health Care $IDX

    Integral Diagnostics (ASX: $IDX) enters merger implementation deed with Capitol Health for proposed acquisition

    Proposed acquisition of Capitol Health by Integral Diagnostics via scheme of arrangement

    July 18, 2024
    integral-diagnostics-asx-idx-announces-transformative-merger-with-capitol-health-idx
    Health Care $IDX

    Integral Diagnostics (ASX: $IDX) announces transformative merger with Capitol Health

    Merger to create ANZ diagnostic imaging leader with significant benefits for patients, doctors, and shareholders

    July 18, 2024
    lumos-diagnostics-asx-ldx-achieves-key-phase-1-milestone-in-hologic-ffn-development-agreement-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) achieves key 'phase 1 milestone' in Hologic fFN development agreement

    Completes phase 1 of Hologic fFN test development agreement valued at US$0.4 million

    May 6, 2024
    lumos-diagnostics-asx-ldx-signs-transformative-development-and-ip-agreements-with-hologic-ldx
    Health Care $LDX

    Lumos Diagnostics (ASX: $LDX) signs transformative development and IP agreements with Hologic

    Reports unaudited revenue of US$4.0 million and positive cash flow for Q3 FY24

    April 24, 2024
    integral-diagnostics-asx-idx-reports-7-2-revenue-growth-in-1h-fy24-idx
    Health Care $IDX

    Integral Diagnostics (ASX: $IDX) reports 7.2% revenue growth in 1H FY24

    Company's operating EBITDA margin increases to 18.7% in the prior corresponding period

    February 20, 2024
    idx-integral-diagnostics-asx-idx-delivers-solid-1h-fy24-results-idx
    Health Care $IDX

    IDX Integral Diagnostics (ASX: $IDX) delivers solid 1H FY24 results

    Reports 7.2% revenue growth and strategic initiatives for future growth

    February 20, 2024
    capitol-health-asx-caj-releases-scheme-booklet-for-proposed-merger-idx
    Health Care $IDX

    Capitol Health (ASX: $CAJ) releases scheme booklet for proposed merger

    Scheme Booklet provides comprehensive details for shareholders' consideration

    September 24, 2024

    IDX

    $IDX

    Integral Diagnostics (ASX: $IDX) highlights strong FY24 performance and strategic growth

    CEO discusses financial success, patient-centric values, and expansion in diagnostic imaging services

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) achieves first phase 2 milestone in hologic fFN development agreement

    Successfully completes milestone under phase 2 of development agreement with Hologic, Inc. for new fetal fibronectin (fFN) test

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) appoints thermo fisher scientific as us distributor for febridx®

    Agreement with Fisher Healthcare to distribute rapid POC respiratory test in the US

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) conducts entitlement offer to raise A$10.0 million

    Entitlement offer aims to fund completion of FebriDx CLIA waiver trial and expand market opportunities

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) completes institutional component of entitlement offer

    Raises approximately A$3.1 million from institutional and sophisticated investors

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) requests trading halt for capital raising announcement

    Company requests halt for announcement on pro-rata accelerated non-renounceable entitlement offer

    IDX

    $IDX

    Integral Diagnostics (ASX: $IDX) enters merger implementation deed with Capitol Health for proposed acquisition

    Proposed acquisition of Capitol Health by Integral Diagnostics via scheme of arrangement

    IDX

    $IDX

    Integral Diagnostics (ASX: $IDX) announces transformative merger with Capitol Health

    Merger to create ANZ diagnostic imaging leader with significant benefits for patients, doctors, and shareholders

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) achieves key 'phase 1 milestone' in Hologic fFN development agreement

    Completes phase 1 of Hologic fFN test development agreement valued at US$0.4 million

    LDX

    $LDX

    Lumos Diagnostics (ASX: $LDX) signs transformative development and IP agreements with Hologic

    Reports unaudited revenue of US$4.0 million and positive cash flow for Q3 FY24

    Load More
    No More Posts
    Related Companies
    CARETEQ LIMITED
    $CTQ
    EBOS GROUP LIMITED
    $EBO
    VISIONFLEX GROUP LIMITED
    $VFX
    SONIC HEALTHCARE LIMITED
    $SHL
    CURVEBEAM AI LIMITED
    $CVB

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions